In 2025, the U.S. healthcare landscape is experiencing two seemingly unrelated yet deeply intertwined trends: the explosive rise of AI-driven healthcare startups U.S. 2025 and the ongoing Ivermectin political policy debates USA. On one hand, venture capital is pouring billions into AI, fueling innovation in diagnostics, treatment, and patient engagement. On the other hand,...